Home | About PM | Editorial board | Search | Ahead of print | Current Issue | Archives | Instructions | Subscribe | Advertise | Contact us |  Login 
Pharmacognosy Magazine
Search Article 
  
Advanced search 
 
ORIGINAL ARTICLE
Year : 2022  |  Volume : 18  |  Issue : 77  |  Page : 112-120

Structure identification and biological activities of a new polysaccharide isolated from Lyophyllum decastes (Fr.) Sing


1 College of Environmental Science and Engineering, China West Normal University, Nanchong, China
2 Key Laboratory of Southwest China Wildlife Resources Conservation, College of Life Sciences, China West Normal University, Nanchong, China
3 Key Laboratory of Southwest China Wildlife Resources Conservation, College of Life Sciences, China West Normal University, Nanchong; Irradiation Preservation Technology Key Laboratory of Sichuan Province, Sichuan Institute of Atomic Energy, Sichuan Province, Chengdu, China

Correspondence Address:
Yiling Hou
Key Laboratory of Southwest China Wildlife Resources Conservation, College of Life Sciences, China West Normal University, 1# Shida Road, Nanchong, Sichuan Province, Nanchong 637009; Irradiation Preservation Technology Key Laboratory of Sichuan Province, Sichuan Institute of Atomic Energy, Sichuan Province, Chengdu 610101
China
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/pm.pm_185_21

Rights and Permissions

Background: Polysaccharide biology, whose core is the structure, function, and edible value of polysaccharides, is regarded as the last great scientific frontier outside the field of protein and nucleic acid research. Materials and Methods: In this study, highperformance gelpermeation chromatography, high-performance liquid chromatography, gas chromatography–mass spectrometry, and nuclear magnetic resonance analysis were performed to identify the structure of a new polysaccharide isolated from Lyophyllum decastes (Fr.) Sing (LDS-1). The anticancer and immunomodulatory ability of the polysaccharides (LDS-1) was also investigated. Results: The results showed that the average molecular weight of LDS-1 was 8681 Da, and the ratio between glucose and galactose was 2:1. Structural analysis revealed four (1 →4)-α-D-Glcp moieties with branches at 6-O position, and the branches consisted of two (1 →6)-β-D–Galp moieties. Our results showed that LDS-1 exhibits immunological activity. At a concentration ranging from 2.5 to 25 μg/mL, LDS-1 could distinctly promote the growth of T lymphocyte, B lymphocyte, and RAW264.7 cells; increase the secretion of IgA, IgD, IgE, IgG, IgM, tumor necrosis factor (TNF)-α, TNF-β, and interleukin-2, and enhance the phagocytotic activity of RAW264.7 cells to phagocytize fluorescent microspheres, when compared with the blank control group (P < 0.01). Furthermore, under in vitro conditions, LDS-1 (2.5-20 μg/mL) exhibited significant antineoplastic activity (P < 0.01) against colon cancer cells (CT26.WT) and S180 cells when compared with the blank control group. However, the inhibition effect was different. The research for antineoplastic activity of LDS-1 in vivo indicated that the tumor inhibition rate was 54.32%. Conclusion: In conclusion, the polysaccharides of LDS-1 exhibited good biological activities, which shows that it can be used as an immunomodulator and an antitumor agent.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed462    
    Printed10    
    Emailed0    
    PDF Downloaded90    
    Comments [Add]    

Recommend this journal